The role of teprotumumab in chronic, clinically active thyroid eye disease

被引：3
|
作者：
Yu, Caroline Y. [1 ]
Simmons, Brittany A. [1 ]
Pham, Chau M. [1 ]
Shriver, Erin M. [1 ]
机构：
[1] Univ Iowa Hosp & Clin, Dept Ophthalmol & Visual Sci, Iowa City, IA 52240 USA
来源：
EYE | 2022年 / 36卷 / 07期
关键词：
D O I：
10.1038/s41433-021-01904-4
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
收藏
页码：1500 / 1501
页数：2
相关论文
共 50 条
  • [1] The role of teprotumumab in chronic, clinically active thyroid eye disease
    Caroline Y. Yu
    Brittany A. Simmons
    Chau M. Pham
    Erin M. Shriver
    Eye, 2022, 36 : 1500 - 1501
  • [2] Teprotumumab for Active Thyroid Eye Disease
    Roos, Jonathan C. P.
    Hyry, Hanna I.
    Murthy, Rachna
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (20): : 1959 - 1959
  • [3] Teprotumumab for chronic thyroid eye disease
    Ozzello, Daniel J.
    Dallalzadeh, Liane O.
    Liu, Catherine Y.
    ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2022, 41 (05): : 539 - 546
  • [4] Teprotumumab for the Treatment of Active Thyroid Eye Disease
    Douglas, R. S.
    Kahaly, G. J.
    Patel, A.
    Sile, S.
    Thompson, E. H. Z.
    Perdok, R.
    Fleming, J. C.
    Fowler, B. T.
    Marcocci, C.
    Marino, M.
    Antonelli, A.
    Dailey, R.
    Harris, G. J.
    Eckstein, A.
    Schiffman, J.
    Tang, R.
    Nelson, C.
    Salvi, M.
    Wester, S.
    Sherman, J. W.
    Vescio, T.
    Holt, R. J.
    Smith, T. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (04): : 341 - 352
  • [5] Teprotumumab for the treatment of chronic thyroid eye disease
    Shoaib Ugradar
    Julia Kang
    Andrea L. Kossler
    Erin Zimmerman
    Jenna Braun
    Andrew R. Harrison
    Swaraj Bose
    Kimberly Cockerham
    Raymond S. Douglas
    Eye, 2022, 36 : 1553 - 1559
  • [6] Teprotumumab for the treatment of chronic thyroid eye disease
    Ugradar, Shoaib
    Kang, Julia
    Kossler, Andrea L.
    Zimmerman, Erin
    Braun, Jenna
    Harrison, Andrew R.
    Bose, Swaraj
    Cockerham, Kimberly
    Douglas, Raymond S.
    EYE, 2022, 36 (08) : 1553 - 1559
  • [7] Teprotumumab, a Novel Biologic for Active Thyroid Eye Disease
    Kahaly, George.
    Sile, Saba
    Thompson, Elizabeth H.
    Vescio, Thomas
    Perdok, Renee
    Sherman, Jeffrey W.
    Smith, Terry J.
    Douglas, Raymond S.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [8] Teprotumumab in thyroid eye disease
    Goldberg, Hila
    Malik, Amina I.
    SAUDI JOURNAL OF OPHTHALMOLOGY, 2024, 38 (01) : 29 - 33
  • [9] Reactivation After Teprotumumab Treatment for Active Thyroid Eye Disease
    Hwang, Catherine J.
    Rebollo, Nicole P.
    Mechels, Keegan B.
    Perry, Julian D.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2024, 263 : 152 - 159
  • [10] Use of teprotumumab in thyroid eye disease
    Greenhill C.
    Nature Reviews Endocrinology, 2021, 17 (7) : 383 - 383
12345